Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Novel Metabolic Tumor Marker

By HospiMedica staff writers
Posted on 20 Dec 2000
A metabolic marker has shown the ability to identify different malignancies with high sensitivity and a specificity of 90-95%. More...
The marker quantifies a tumor-specific enzyme called tumor M2-PK.

The majority of human tumors strongly overexpress an isoform of the glycolytic enzyme pyruvate kinase, tumor M2-PK, which is quantitatively detectable in body fluids. The concentration of this tumor metabolic marker correlates with the tumor stage, indicating a strong association with the tumor load. tumors. Thus, the marker reflects tumor regression and progression during chemotherapy and is suitable for disease monitoring and therapy control.

ScheBo Biotech AG (Giessen, Germany) has developed a highly sensitive enzyme-linked immunosorbent assay (ELISA) that allows measurement of M2-PK in EDTA plasma. The M2-PK test is based on two monoclonal antibodies that specifically react with tumor M2-PK and do not cross-react with the other isoforms of pyruvate kinase. The results of clinical studies show the test is well-suited for identifying gastrointestinal tumors (colon, rectal, gastric, esophageal, and pancreatic cancer). The company notes the test can also be used to identify breast, bronchial, and lung cancer.

ScheBo Biotech develops, produces, and globally distributes test systems for human and veterinary diagnostics as well as for food analysis.



Related Links:
ScheBo

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.